Cardiac Pacemaker and/or ICD Control and Monitor

• US 20070219592A1
• Filed: 02/26/2007
• Published: 09/20/2007
• Est. Priority Date: 02/28/2006
• Status: Abandoned Application

• Current Assignee: Physical Logic AG
• Original Assignee: Physical Logic AG
• Inventors: Ofek, Eran, Axelrod, Noel, Zipes, Douglas
• Application Number:
  US11/678,689
• Publication Number:
  US 20070219592A1
• Time in Patent Office: Days
• US Class Current: 607/19
• CPC Class Codes: A61N 1/36542 controlled by body motion, e.g. acceleration
• CPC Class Codes: A61N 1/36578 controlled by mechanical motion of the heart wall, e.g. measured by an accelerometer or microphone
• CPC Class Codes: A61N 1/36585 controlled by two or more physical parameters
• CPC Class Codes: A61N 1/3925 Monitoring; Protecting
• CPC Class Codes: A61N 1/3962 in combination with another heart therapy
• CPC Class Codes: A61N 1/39622 Pacing therapy

Abstract

A cardiac pacemaker and/or ICD device deploys a plurality of three-dimensional accelerometers to characterize and distinguish between the local motion of the heart and the gross movement of the patient. The relative difference between these movements is used to distinguish between false negatives results of the electrogram reading to avoid triggering an unneeded defibrillation pulse, or increasing the pacing rate when the patient is exercising.

Claims

1. A biomedical transducer comprising:

a) a first 3DA to be disposed on the subject to measure the gross motion thereof,

b) a second 3DA to be disposed in close proximity to the subject'"'"'s heart to measure the local movement of the heart,

c) means for comparing the output of the first and second 3DA'"'"'s to determine the relative movement of the heart,

d) means to modulate the output of a pacemaker or ICD device in response to the relative movement of at least one of the heart and the subject.

2. A biomedical transducer according to claim 1 and further comprising:

a) means to detect and locate the source of fibrillation in the heart,

b) means to apply a defibrillating or other therapeutic electric discharge in close proximity to the source of fibrillation or fluttering in the heart.

3. A biomedical transducer according to claim 1 and further comprising means to modulate the power of a defibrillating or other therapeutic electric discharge.

4. A biomedical transducer according to claim 2 and further comprising means to modulate the power of the defibrillating or other therapeutic electric discharge.

5. A method of treating cardiac patients, the method comprising the steps of:

a) providing the patient with at least one of a cardiac pacemaker or ICD,

b) providing at least a first 3DA disposed on the patient to measure the gross motion thereof,

c) providing at least a second 3DA disposed in close proximity to the heart of the patient to measure the local movement of the heart,

d) determining the patient'"'"'s level of physical activity from at least one of the out of the first and second 3DA,

e) modulating the output of the pacemaker in response to patient'"'"'s level of physical activity.

6. A method according to claim 5 wherein the pacemaker or ICD is implanted within the patient.

7. A method according to claim 5 wherein the first 3DA is in the portion of the pacemaker or ICD containing the battery and the second 3DA is on an electrical lead implanted in or in electrical communication with the heart.

8. A method of treating cardiac patients, the method comprising the steps of

a) providing the patient with an ICD,

b) providing at least a first 3DA disposed on the patient to measure the gross motion thereof,

c) providing at least a second 3DA disposed in close proximity to the heart of the patient,

d) comparing the movement between 1st and 2nd accelerometer to measure the local movement of the heart,

e) verifying the accuracy of electrogram measurements by the ICD by confirming that the movement of a least a portion of the heart corresponds with electrical activity detected by the electrogram,

f) applying at least one appropriate therapeutic shock via the ICD when the electrogram measurement is verified.

9. A method according to claim 8 wherein said step of detecting computing determining is in response to the ICD detecting at least one of defibrillation and tachycardia.

10. A method according to claim 8 wherein the first 3DA is in the portion of the pacemaker or ICD containing the battery and the second 3DA is on an electrical lead implanted in or in electrical communication with the heart.

11. A method according to claim 8 wherein the pacemaker or ICD is implanted within the patient.

12. A method of treating cardiac patients, the method comprising the steps of:

a) providing the patient with an ICD,

b) providing at least a first 3DA disposed on the patient to measure the gross motion thereof,

c) providing at least one additional accelerometer disposed in close proximity to a local region of the heart of the patient,

d) comparing the output of the first 3DA and the least one additional accelerometer to determine the relative local movement of at least a portion of the heart,

e) computing at least one of the location and magnitude of cardiac fibrillation and/or fluttering from said comparison step,

f) determining the appropriate therapeutic discharge from the ICD for least one of the location and magnitude of the cardiac fibrillation and/or fluttering form the said comparison.

13. A method according to claim 12 wherein the first 3DA is in the portion of the pacemaker or ICD containing the battery and the second accelerometer is on an electrical lead implanted in or in electrical communication with the heart.

14. A method according to claim 12 wherein said step of detecting computing determining is in response to the ICD detecting at least one of defibrillation and tachycardia.

15. A method according to claim 12 wherein a plurality of additional accelerometers are disposed in close proximity to different local regions of the heart of the patient.

16. A method according to claim 12 wherein the second accelerometer is a two-dimensional accelerometer.

17. A method according to claim 12 wherein the second accelerometer is a 3DA.

18. A method according to claim 12 pacemaker or ICD is internal/external.

19. A method according to claim 17 wherein the first 3DA is in the portion of the ICD containing the battery and the second 3DA is on an electrical lead implanted in or in electrical communication with the heart.

20. A method according to claim 12 wherein said step of comparing the output of the first 3DA and the least one additional accelerometer to determine the relative local movement of at least a portion of the heart is in response to the ICD detecting at least one of defibrillation and tachycardia.

21. A method according to claim 12 wherein at least one accelerometer is coupled to a cardiac stent.